Page 18 - JSOM Summer 2024

and Oxyband, He receives research grant support from the 4. Nessen SC, Le TD, Gurney JM. Combat Casualty Care Statis-
DoD, DARPA, NIH and CSL focused on hemorrhage control tics as Outcome Measures for Medical Treatment on the Battle-
and resuscitation. He consults with BARDA, WFIRM, and As- field: A Review and Reconsideration of the Data. Curr Trauma
pen Medical, is the co-inventor of the Junctional Emergency Rep. 2019;5(4):187–194. https://doi.org/10.1007/s40719-019-
00177-3
Tourniquet Tool and receive royalties from UT Health. The 5. Howard JT, Kotwal RS, Stern CA, et al. Use of combat casualty
other authors have nothing to disclose. care data to assess the US military trauma system during the Af-
ghanistan and Iraq conflicts, 2001–2017. JAMA Surg. 2019;154
This article was reviewed by Public Affairs and Operational (7):600–608. doi:10.1001/jamasurg.2019.0151
Security at the Defense Health Agency, as well as the Chief of 6. Cannon JW, Holena DN, Geng Z, et al. Comprehensive analysis
the Joint Trauma System, and approved for public release on of combat casualty outcomes in US service members from the be-
April 10, 2023. ginning of World War II to the end of Operation Enduring Free-
dom. J Trauma Acute Care Surg. 2020;89(2S Suppl 2):S8–S15.
doi:10.1097/TA.0000000000002789
Funding 7. Harrison WY, Wardian JL, Sosnov JA, et al. Recommended medi-
No funding was received for this work. cal and non-medical factors to assess military preventable deaths:
subject matter experts provide valuable insights. BMJ Mil Health.
References 2020;166(E):e47–e52. doi:10.1136/jramc-2019-001193
1. Holcomb JB, Stansbury LG, Champion HR, Wade C, Bellamy RF. 8. US Department of Defense. Immediate release casualty status.
Understanding combat casualty care statistics. J Trauma. 2006;60 April 24, 2023. Accessed April 25, 2023 https://www.defense.
(2):397–401. doi:10.1097/01.ta.0000203581.75241.f1 gov/casualty.pdf..
2. Rasmussen TE, Gross KR, Baer DG. Where do we go from here? 9. Shackelford SA, Del Junco DJ, Reade MC, et al. Association
Preface. US Military Health System Research Symposium, August of time to craniectomy with survival in patients with severe
2013. J Trauma Acute Care Surg. 2013;75(2 Suppl 2):S105–S106. combat-related brain injury. Neurosurg Focus. 2018;45(6):E2.
doi:10.1097/TA.0b013e3182a0707b doi:10.3171/2018.9.FOCUS18404
3. Nessen SC, Gurney J, Rasmussen TE, et al. Unrealized potential of 10. Holcomb JB, McMullin NR, Pearse L, et al. Causes of death in
the US military battlefield trauma system: DOW rate is higher in U.S. Special Operations Forces in the global war on terrorism:
Iraq and Afghanistan than in Vietnam, but CFR and KIA rate are 2001–2004. Ann Surg. 2007;245(6):986–991. doi:10.1097/01.
lower. J Trauma Acute Care Surg. 2018;85(1S Suppl 2):S4–S12. sla.0000259433.03754.98
doi:10.1097/TA.0000000000001969 11. Eastridge BJ, Mabry RL, Seguin P, et al. Death on the battlefield
(2001-2011): implications for the future of combat casualty
care. J Trauma Acute Care Surg. 2012;73(6 Suppl 5):S431–S437.
doi:10.1097/TA.0b013e3182755dcc
12. Mazuchowski EL, Kotwal RS, Janak JC, et al. Mortality review
of US Special Operations Command battle-injured fatalities. J
Trauma Acute Care Surg. 2020;88(5):686–695. doi:10.1097/TA.
0000000000002610
13. Kotwal RS, Mazuchowski EL, Janak JC, et al. United States mili-
tary fatalities during Operation New Dawn. J Trauma Acute Care
Surg. 2021;91(2):375–383. doi:10.1097/TA.0000000000003268
14. Kotwal RS, Janak JC, Howard JT, et al. United States Military
Fatalities During Operation Inherent Resolve and Operation
Freedom’s Sentinel. Mil Med. 2023;188(9–10):3045–3056. doi:
10.1093/milmed/usac119
15. Le TD, Gurney JM, Nnamani NS, et al. A 12-Year Analysis of Non-
battle Injury Among US Service Members Deployed to Iraq and
Afghanistan. JAMA Surg. 2018;153(9):800–807. doi:10.1001/
jamasurg.2018.116
16. Le TD, Gurney JM, Akers KS, et al. Analysis of nonbattle deaths
among U.S. service members in the deployed environment. Ann Surg.
2021;274(5):e445–e451. doi:10.1097/SLA.0000000000005047
FRONTLINE PMID: 38869945; DOI: 10.55460/XBJF-AQPX
DEFENSE FOR
LIFE-THREATENING
BLEEDING
EMERGENCIES.
The first and only
FDA-cleared chitosan
dry powder in aerosol form.
Available in Rx and OTC
This innovative product acts as a physical barrier,
effectively sealing wounds to stop blood flow.

+1 (833) 311-SEAL SEALwoundcare.com

16 | JSOM Volume 24, Edition 2 / Summer 2024